Pharmacological and clinical profile of ipragliflozin (Suglat®): a new therapeutic agent for type 2 diabetes
2014 ◽
Vol 18
(3)
◽
pp. 400
◽
2019 ◽
Vol 23
(3)
◽
pp. 293
2014 ◽
Vol 8
(2)
◽
pp. 72-74
◽
Keyword(s):
2020 ◽
2020 ◽